Loading...
Elixinol Wellness Limited
ELLXF•PNK
HealthcareDrug Manufacturers - Specialty & Generic
$0.004
$-0.00(-55.81%)
Elixinol Wellness Limited (ELLXF) Stock Overview
Explore Elixinol Wellness Limited’s financial performance, market position, analyst ratings, and future outlook.
Revenue Growth
80.87%
↑ 80.87%
Profit Growth
$-0.01
↑ 77.06%
EPS Growth
$-0.01
↑ 9.76%
Operating Margin
-41.96%
↑ 42.10%
ROE
-78.66%
↑ 77.06%
Dividend Yield
0.00%
Analyst Recommendations data is not available for ELLXFAnalyst Recommendations details for ELLXF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Elixinol Wellness Limited, through its subsidiaries, manufactures and distributes hemp derived nutraceuticals, cosmetics, and food products under the Elixinol and Hemp Foods Australia brands in the Americas, Europe, and Australia. It offers hemp derived cannabidiol and food products, dietary supplements, topicals, and skincare products. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is headquartered in Sydney, Australia.
CEO
Ms. Josephine Mary Lorenz
Headquarters
680 George Street, Sydney, NSW
Founded
2018